The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Researchers say the drugs should be explored as a potential treatment for obese people with the respiratory condition.

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...